Evaluation	B:C0220825
of	O
Choroidal	O
Thickness	O
in	O
Patients	O
with	O
Pseudoexfoliation	O
Syndrome	I:C0206368
and	O
Pseudoexfoliation	O
Glaucoma	I:C0206368
.	O

Evaluation	O
of	O
Choroidal	B:C0008520
Thickness	O
in	O
Patients	O
with	O
Pseudoexfoliation	O
Syndrome	I:C0206368
and	O
Pseudoexfoliation	O
Glaucoma	I:C0206368
.	O

Evaluation	O
of	O
Choroidal	O
Thickness	O
in	O
Patients	O
with	O
Pseudoexfoliation	B:C0206368
Syndrome	I:C0206368
and	O
Pseudoexfoliation	O
Glaucoma	I:C0206368
.	O

Evaluation	O
of	O
Choroidal	O
Thickness	O
in	O
Patients	O
with	O
Pseudoexfoliation	O
Syndrome	I:C0206368
and	O
Pseudoexfoliation	B:C0206368
Glaucoma	I:C0206368
.	O

To	O
compare	O
the	O
macular	O
and	O
peripapillary	B:C0442163
choroidal	O
thickness	O
in	O
eyes	O
with	O
pseudoexfoliation	O
(	I:C0206368
PEX	I:C0206368
)	I:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
with	O
the	O
normal	O
eyes	O
of	O
healthy	O
controls	O
.	O

To	O
compare	O
the	O
macular	O
and	O
peripapillary	O
choroidal	B:C0008520
thickness	O
in	O
eyes	O
with	O
pseudoexfoliation	O
(	I:C0206368
PEX	I:C0206368
)	I:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
with	O
the	O
normal	O
eyes	O
of	O
healthy	O
controls	O
.	O

To	O
compare	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
eyes	B:C0015392
with	O
pseudoexfoliation	O
(	I:C0206368
PEX	I:C0206368
)	I:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
with	O
the	O
normal	O
eyes	O
of	O
healthy	O
controls	O
.	O

To	O
compare	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
eyes	O
with	O
pseudoexfoliation	B:C0206368
(	I:C0206368
PEX	I:C0206368
)	I:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
with	O
the	O
normal	O
eyes	O
of	O
healthy	O
controls	O
.	O

To	O
compare	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
eyes	O
with	O
pseudoexfoliation	O
(	I:C0206368
PEX	I:C0206368
)	I:C0206368
syndrome	I:C0206368
and	O
PEX	B:C0206368
glaucoma	I:C0206368
with	O
the	O
normal	O
eyes	O
of	O
healthy	O
controls	O
.	O

To	O
compare	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
eyes	O
with	O
pseudoexfoliation	O
(	I:C0206368
PEX	I:C0206368
)	I:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
with	O
the	O
normal	O
eyes	B:C0015392
of	O
healthy	O
controls	O
.	O

In	O
this	O
prospective	B:C0033522
study	I:C0033522
,	O
30	O
eyes	O
of	O
30	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
,	O
28	O
eyes	O
of	O
28	O
patients	O
with	O
PEX	O
glaucoma	I:C0206368
,	O
and	O
30	O
eyes	O
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
30	O
eyes	B:C0015392
of	O
30	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
,	O
28	O
eyes	O
of	O
28	O
patients	O
with	O
PEX	O
glaucoma	I:C0206368
,	O
and	O
30	O
eyes	O
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
30	O
eyes	O
of	O
30	O
patients	O
with	O
PEX	B:C0206368
syndrome	I:C0206368
,	O
28	O
eyes	O
of	O
28	O
patients	O
with	O
PEX	O
glaucoma	I:C0206368
,	O
and	O
30	O
eyes	O
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
30	O
eyes	O
of	O
30	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
,	O
28	O
eyes	B:C0015392
of	O
28	O
patients	O
with	O
PEX	O
glaucoma	I:C0206368
,	O
and	O
30	O
eyes	O
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
30	O
eyes	O
of	O
30	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
,	O
28	O
eyes	O
of	O
28	O
patients	O
with	O
PEX	B:C0206368
glaucoma	I:C0206368
,	O
and	O
30	O
eyes	O
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
30	O
eyes	O
of	O
30	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
,	O
28	O
eyes	O
of	O
28	O
patients	O
with	O
PEX	O
glaucoma	I:C0206368
,	O
and	O
30	O
eyes	B:C0015392
of	O
30	O
age	O
-	O
matched	O
healthy	O
subjects	O
were	O
enrolled	O
.	O

Choroidal	B:C0008520
thicknesses	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
were	O
measured	O
by	O
using	O
spectral	O
domain	I:C3876157
optical	I:C3876157
coherence	I:C3876157
tomography	I:C3876157
.	O

Choroidal	O
thicknesses	O
in	O
the	O
macular	O
and	O
peripapillary	B:C0442163
areas	O
were	O
measured	O
by	O
using	O
spectral	O
domain	I:C3876157
optical	I:C3876157
coherence	I:C3876157
tomography	I:C3876157
.	O

Choroidal	O
thicknesses	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	B:C0205146
were	O
measured	O
by	O
using	O
spectral	O
domain	I:C3876157
optical	I:C3876157
coherence	I:C3876157
tomography	I:C3876157
.	O

Choroidal	O
thicknesses	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
were	O
measured	O
by	O
using	O
spectral	B:C3876157
domain	I:C3876157
optical	I:C3876157
coherence	I:C3876157
tomography	I:C3876157
.	O

Gender	O
,	O
age	O
,	O
and	O
axial	O
length	O
did	O
not	B:C1273937
significantly	I:C1273937
differ	O
between	O
the	O
groups	O
(	O
all	O
,	O
p	O
>	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	B:C0008520
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
(	O
except	O
the	O
superior	O
quadrant	O
)	O
in	O
the	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	O
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	B:C0442163
areas	O
(	O
except	O
the	O
superior	O
quadrant	O
)	O
in	O
the	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	O
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	B:C0205146
(	O
except	O
the	O
superior	O
quadrant	O
)	O
in	O
the	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	O
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
(	O
except	O
the	O
superior	B:C1282910
quadrant	O
)	O
in	O
the	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	O
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
(	O
except	O
the	O
superior	O
quadrant	B:C1631280
)	O
in	O
the	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	O
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
(	O
except	O
the	O
superior	O
quadrant	O
)	O
in	O
the	O
patients	O
with	O
PEX	B:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
choroidal	O
thickness	O
in	O
the	O
macular	O
and	O
peripapillary	O
areas	O
(	O
except	O
the	O
superior	O
quadrant	O
)	O
in	O
the	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
and	O
PEX	B:C0206368
glaucoma	I:C0206368
were	O
lower	O
compared	O
with	O
controls	O
(	O
all	O
p	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
values	O
of	O
the	O
macular	O
and	O
peripapillary	B:C0442163
choroidal	O
thickness	O
in	O
the	O
PEX	O
glaucoma	I:C0206368
group	O
were	O
lower	O
compared	O
with	O
PEX	O
syndrome	I:C0206368
group	O
;	O
however	O
this	O
difference	O
was	O
not	O
significant	I:C1273937
.	O

The	O
mean	O
values	O
of	O
the	O
macular	O
and	O
peripapillary	O
choroidal	B:C0008520
thickness	O
in	O
the	O
PEX	O
glaucoma	I:C0206368
group	O
were	O
lower	O
compared	O
with	O
PEX	O
syndrome	I:C0206368
group	O
;	O
however	O
this	O
difference	O
was	O
not	O
significant	I:C1273937
.	O

The	O
mean	O
values	O
of	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
the	O
PEX	B:C0206368
glaucoma	I:C0206368
group	O
were	O
lower	O
compared	O
with	O
PEX	O
syndrome	I:C0206368
group	O
;	O
however	O
this	O
difference	O
was	O
not	O
significant	I:C1273937
.	O

The	O
mean	O
values	O
of	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
the	O
PEX	O
glaucoma	I:C0206368
group	O
were	O
lower	O
compared	O
with	O
PEX	B:C0206368
syndrome	I:C0206368
group	O
;	O
however	O
this	O
difference	O
was	O
not	O
significant	I:C1273937
.	O

The	O
mean	O
values	O
of	O
the	O
macular	O
and	O
peripapillary	O
choroidal	O
thickness	O
in	O
the	O
PEX	O
glaucoma	I:C0206368
group	O
were	O
lower	O
compared	O
with	O
PEX	O
syndrome	I:C0206368
group	O
;	O
however	O
this	O
difference	O
was	O
not	B:C1273937
significant	I:C1273937
.	O

The	O
findings	B:C0243095
of	O
this	O
study	O
revealed	O
that	O
macular	O
and	O
peripapillary	O
choroidal	O
thicknesses	O
were	O
decreased	O
in	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
cases	O
.	O

The	O
findings	O
of	O
this	O
study	B:C2603343
revealed	O
that	O
macular	O
and	O
peripapillary	O
choroidal	O
thicknesses	O
were	O
decreased	O
in	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
cases	O
.	O

The	O
findings	O
of	O
this	O
study	O
revealed	O
that	O
macular	O
and	O
peripapillary	B:C0442163
choroidal	O
thicknesses	O
were	O
decreased	O
in	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
cases	O
.	O

The	O
findings	O
of	O
this	O
study	O
revealed	O
that	O
macular	O
and	O
peripapillary	O
choroidal	B:C0008520
thicknesses	O
were	O
decreased	O
in	O
PEX	O
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
cases	O
.	O

The	O
findings	O
of	O
this	O
study	O
revealed	O
that	O
macular	O
and	O
peripapillary	O
choroidal	O
thicknesses	O
were	O
decreased	O
in	O
PEX	B:C0206368
syndrome	I:C0206368
and	O
PEX	O
glaucoma	I:C0206368
cases	O
.	O

The	O
findings	O
of	O
this	O
study	O
revealed	O
that	O
macular	O
and	O
peripapillary	O
choroidal	O
thicknesses	O
were	O
decreased	O
in	O
PEX	O
syndrome	I:C0206368
and	O
PEX	B:C0206368
glaucoma	I:C0206368
cases	O
.	O

The	O
role	O
of	O
choroid	B:C0008520
in	O
the	O
development	O
of	O
glaucomatous	O
damage	O
in	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
remains	O
unclear	O
.	O

The	O
role	O
of	O
choroid	O
in	O
the	O
development	O
of	O
glaucomatous	B:C0017601
damage	O
in	O
patients	O
with	O
PEX	O
syndrome	I:C0206368
remains	O
unclear	O
.	O

The	O
role	O
of	O
choroid	O
in	O
the	O
development	O
of	O
glaucomatous	O
damage	O
in	O
patients	O
with	O
PEX	B:C0206368
syndrome	I:C0206368
remains	O
unclear	O
.	O

